Jiangzhong Pharmaceutical Co., Ltd. Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Million

Consolidate Quarterly Results

Jun'26

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Net Sales

896.12

1,036.17

1,286.33

792.05

957.02

1,184.10

1,463.57

Other Operating Income

0.00

Total Operating income

896.12

1,036.17

1,286.33

792.05

957.02

1,184.10

1,463.57

Raw Material Cost

325.76

343.31

477.58

292.60

351.96

389.54

669.45

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

0.44

0.28

1.10

0.23

0.25

0.23

1.45

Selling and Distribution Expenses

303.18

331.49

497.16

276.67

270.46

445.68

532.92

Other Expenses

1.58

2.47

5.06

2.55

3.55

2.19

4.70

Total Expenditure (Excl Depreciation)

645.23

699.79

1,026.39

594.99

658.13

857.40

1,250.79

Operating Profit (PBDIT) excl Other Income

250.9

336.4

259.9

197.10000000000002

298.9

326.70000000000005

212.8

Other Income

44.60

28.08

62.57

27.86

49.15

50.32

42.82

Operating Profit (PBDIT)

316.46

399.48

325.36

260.64

380.70

395.67

264.89

Interest

0.44

0.28

1.10

0.23

0.25

0.23

1.45

Exceptional Items

2.09

0.27

4.06

0.42

0.63

0.05

-9.47

Gross Profit (PBDT)

570.36

692.86

808.76

499.46

605.06

794.56

794.12

Depreciation

38.94

39.13

37.03

36.29

Profit Before Tax

279.16

360.52

289.19

221.70

344.05

358.46

217.67

Tax

47.67

48.54

44.16

37.19

91.52

52.30

41.44

Provisions and contingencies

0.00

Profit After Tax

203.36

288.04

223.24

161.11

237.42

284.91

153.85

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

203.36

288.04

223.24

161.11

237.42

284.91

153.85

Share in Profit of Associates

0.00

Minority Interest

27.57

23.91

21.63

22.16

15.30

21.78

22.76

Other related items

0.00

Consolidated Net Profit

230.93

311.95

244.86

183.27

252.72

306.70

176.61

Equity Capital

0.00

Face Value

1.0

Reserves

3,958.90

4,316.11

4,022.81

3,795.54

3,946.03

4,148.19

3,862.81

Earnings per share (EPS)

0.32

0.46

0.36

0.26

0.38

0.45

0.25

Diluted Earnings per share

0.32

0.46

0.36

0.26

0.38

0.45

0.25

Operating Profit Margin (Excl OI)

25.99%

32.08%

17.39%

24.45%

30.77%

26.04%

12.69%

Gross Profit Margin

35.5%

38.55%

25.52%

32.93%

39.82%

33.4%

17.35%

PAT Margin

22.69%

27.8%

17.35%

20.34%

24.81%

24.06%

10.51%

Public Share Holdings (%)

0.0%

Pledged Promotor Holding (%)

0.0%

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Jun 2026 is -13.52% vs -19.44% in Mar 2026

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2026 is -25.99% vs 27.40% in Mar 2026

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2026 is -26.79% vs 41.32% in Mar 2026

Interest

QoQ Growth in quarter ended Jun 2026 is 33.33% vs -72.73% in Mar 2026

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

Compare Quarterly Results Of Jiangzhong Pharmaceutical Co., Ltd. With

Select Peers

Figures in Million

Consolidate Quarterly Results

Change(CNY)

Change(%)

Net Sales

896.12

Other Operating Income

0.00

Total Operating income

896.12

Raw Material Cost

325.76

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

0.00

Power Cost

0.00

Manufacturing Expenses

0.44

Selling and Distribution Expenses

303.18

Other Expenses

1.58

0.00

1.58

Total Expenditure (Excl Depreciation)

645.23

Operating Profit (PBDIT) excl Other Income

250.88

0.00

250.88

Other Income

44.60

Operating Profit (PBDIT)

316.46

Interest

0.44

Exceptional Items

2.09

Gross Profit (PBDT)

570.36

Depreciation

38.94

Profit Before Tax

279.16

Tax

47.67

Provisions and contingencies

0.00

Profit After Tax

203.36

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

203.36

Share in Profit of Associates

0.00

Minority Interest

27.57

Other related items

0.00

Consolidated Net Profit

230.93

Equity Capital

0.00

Face Value

1.00

0.00

Reserves

3,958.90

Earnings per share (EPS)

0.32

Diluted Earnings per share

0.32

Operating Profit Margin (Excl OI)

25.99%

0.00

25.99%

Gross Profit Margin

35.50%

0.00

35.50%

PAT Margin

22.69%

0.00

22.69%

Public Share Holdings (%)

0.00

0.00%

Pledged Promotor Holding (%)

0.00

0.00%

Quarterly - Net Sales

Net Sales 89.61 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is -13.52% vs -19.44% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -6.36% vs 1.26% in Jun 2025

Quarterly - Consolidate Net Profit

Consolidate Net Profit 23.09 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is -25.99% vs 27.40% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -8.63% vs 5.34% in Jun 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 27.19 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is -26.79% vs 41.32% in Mar 2026

YoY Growth in quarter ended Jun 2026 is -17.98% vs 20.90% in Jun 2025

Quarterly - Interest

Interest 0.04 Million

in Jun 2026

Figures in Million

QoQ Growth in quarter ended Jun 2026 is 33.33% vs -72.73% in Mar 2026

YoY Growth in quarter ended Jun 2026 is 33.33% vs 50.00% in Jun 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 25.99%

in Jun 2026

Figures in %

QoQ Growth in quarter ended Jun 2026 has fallen from Mar 2026

YoY Growth in quarter ended Jun 2026 has fallen from Jun 2025